George Poste

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Monsanto Co Feb. 20, 2003 - June 7, 2018
George Poste's trades of Caris Life Sciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
440.96
Quantity 57,069
Value US$4,859,895
Transaction date
Proposed sale
Price
332.14
Quantity 70,563
Value US$378,115
Transaction date
Proposed sale
Price
94.10
Quantity 35,205
Value US$1,779,829
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
45.71
Quantity 60,000 -33.6%
Value US$2,742,600
US Exelixis Inc (EXEL)
Transaction date
Proposed sale
Price
45.71
Quantity 60,000
Value US$2,742,468
US Exelixis Inc (EXEL)
Transaction date
Proposed sale
Price
45.99
Quantity 20,634
Value US$948,958
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
45.99
Quantity 20,634 -10.9%
Value US$948,958
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
34.74
Quantity 15,874 -8.6%
Value US$551,463
US Exelixis Inc (EXEL)
Transaction date
Proposed sale
Price
34.74
Quantity 15,874
Value US$551,431
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
34.00
Quantity 30,000 -15.1%
Value US$1,020,000
US Exelixis Inc (EXEL)
Transaction date
Proposed sale
Price
34.00
Quantity 30,000
Value US$1,020,112
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
26.89
Quantity 33,725 -14.5%
Value US$906,865
US Exelixis Inc (EXEL)
Transaction date
Proposed sale
Price
26.89
Quantity 33,725
Value US$906,746
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
20.96
Quantity 11,686 -5.2%
Value US$244,939
US Exelixis Inc (EXEL)
Transaction date
Proposed sale
Price
22.60
Quantity 11,686
Value US$264,104
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
16.68
Quantity 40,000 -17.2%
Value US$667,200
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
25.61
Quantity 30,000 -21.0%
Value US$768,300
US Exelixis Inc (EXEL)
Transaction date
Planned sale
Price
23.89
Quantity 3,860 -3.6%
Value US$92,215
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-24 2026-08-24
PrS Proposed sale
57,069
440.96
US$4,859,895 		57,069 440.96 US$4,859,895
2026-08-07 2026-08-07
PrS Proposed sale
70,563
332.14
US$378,115 		70,563 332.14 US$378,115
2026-08-03 2026-08-03
PrS Proposed sale
35,205
94.10
US$1,779,829 		35,205 94.10 US$1,779,829
2026-05-08 2026-05-07
US Exelixis Inc (EXEL)
S Sale
60,000 -33.6%
45.71
US$2,742,600 		60,000 -33.6% 45.71 US$2,742,600
2026-05-07 2026-05-07
US Exelixis Inc (EXEL)
PrS Proposed sale
60,000
45.71
US$2,742,468 		60,000 45.71 US$2,742,468
2025-05-16 2025-05-16
US Exelixis Inc (EXEL)
PrS Proposed sale
20,634
45.99
US$948,958 		20,634 45.99 US$948,958
2025-05-16 2025-05-16
US Exelixis Inc (EXEL)
S Sale
20,634 -10.9%
45.99
US$948,958 		20,634 -10.9% 45.99 US$948,958
2025-02-19 2025-02-14
US Exelixis Inc (EXEL)
S Sale
15,874 -8.6%
34.74
US$551,463 		15,874 -8.6% 34.74 US$551,463
2025-02-14 2025-02-14
US Exelixis Inc (EXEL)
PrS Proposed sale
15,874
34.74
US$551,431 		15,874 34.74 US$551,431
2024-11-05 2024-11-01
US Exelixis Inc (EXEL)
S Sale
30,000 -15.1%
34.00
US$1,020,000 		30,000 -15.1% 34.00 US$1,020,000
2024-11-01 2024-11-01
US Exelixis Inc (EXEL)
PrS Proposed sale
30,000
34.00
US$1,020,112 		30,000 34.00 US$1,020,112
2024-08-12 2024-08-08
US Exelixis Inc (EXEL)
S Sale
33,725 -14.5%
26.89
US$906,865 		33,725 -14.5% 26.89 US$906,865
2024-08-08 2024-08-08
US Exelixis Inc (EXEL)
PrS Proposed sale
33,725
26.89
US$906,746 		33,725 26.89 US$906,746
2024-05-22 2024-05-21
US Exelixis Inc (EXEL)
S Sale
11,686 -5.2%
20.96
US$244,939 		11,686 -5.2% 20.96 US$244,939
2024-05-07 2024-05-07
US Exelixis Inc (EXEL)
PrS Proposed sale
11,686
22.60
US$264,104 		11,686 22.60 US$264,104
2022-12-01 2022-11-29
US Exelixis Inc (EXEL)
S Sale
40,000 -17.2%
16.68
US$667,200 		40,000 -17.2% 16.68 US$667,200
2020-05-08 2020-05-07
US Exelixis Inc (EXEL)
S Sale
30,000 -21.0%
25.61
US$768,300 		30,000 -21.0% 25.61 US$768,300
2019-03-29 2019-03-29
US Exelixis Inc (EXEL)
PlS Planned sale
3,860 -3.6%
23.89
US$92,215 		3,860 -3.6% 23.89 US$92,215